Literature DB >> 28213973

Transforming growth factor β induces bone marrow mesenchymal stem cell migration via noncanonical signals and N-cadherin.

Maria Jose Dubon1, Jinyeong Yu1, Sanghyuk Choi1, Ki-Sook Park2,3.   

Abstract

Transforming growth factor-beta (TGF-β) induces the migration and mobilization of bone marrow-derived mesenchymal stem cells (BM-MSCs) to maintain bone homeostasis during bone remodeling and facilitate the repair of peripheral tissues. Although many studies have reported the mechanisms through which TGF-β mediates the migration of various types of cells, including cancer cells, the intrinsic cellular mechanisms underlying cellular migration, and mobilization of BM-MSCs mediated by TGF-β are unclear. In this study, we showed that TGF-β activated noncanonical signaling molecules, such as Akt, extracellular signal-regulated kinase 1/2 (ERK1/2), focal adhesion kinase (FAK), and p38, via TGF-β type I receptor in human BM-MSCs and murine BM-MSC-like ST2 cells. Inhibition of Rac1 by NSC23766 and Src by PP2 resulted in impaired TGF-β-mediated migration. These results suggested that the Smad-independent, noncanonical signals activated by TGF-β were necessary for migration. We also showed that N-cadherin-dependent intercellular interactions were required for TGF-β-mediated migration using functional inhibition of N-cadherin with EDTA treatment and a neutralizing antibody (GC-4 antibody) or siRNA-mediated knockdown of N-cadherin. However, N-cadherin knockdown did not affect the global activation of noncanonical signals in response to TGF-β. Therefore, these results suggested that the migration of BM-MSCs in response to TGF-β was mediated through N-cadherin and noncanonical TGF-β signals.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  N-cadherin; mesenchymal stem cells; migration; transforming growth factor β

Mesh:

Substances:

Year:  2017        PMID: 28213973     DOI: 10.1002/jcp.25863

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  24 in total

Review 1.  Preconditioning Methods to Improve Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Bone Regeneration-A Systematic Review.

Authors:  Fernanda Campos Hertel; Aline Silvestrini da Silva; Adriano de Paula Sabino; Fabrício Luciani Valente; Emily Correna Carlo Reis
Journal:  Biology (Basel)       Date:  2022-05-11

Review 2.  Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate.

Authors:  Cristina Sobacchi; Eleonora Palagano; Anna Villa; Ciro Menale
Journal:  Front Bioeng Biotechnol       Date:  2017-05-17

3.  Profibrotic epithelial TGF-β1 signaling involves NOX4-mitochondria cross talk and redox-mediated activation of the tyrosine kinase FYN.

Authors:  Carmen Veith; Milena Hristova; Karamatullah Danyal; Aida Habibovic; Christopher M Dustin; John E McDonough; Bart M Vanaudenaerde; Michael Kreuter; Marc A Schneider; Nicolas Kahn; Frederik J van Schooten; Agnes W Boots; Albert van der Vliet
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-12-16       Impact factor: 5.464

4.  Link Protein N-Terminal Peptide as a Potential Stimulating Factor for Stem Cell-Based Cartilage Regeneration.

Authors:  Ruijun He; Baichuan Wang; Min Cui; Zekang Xiong; Hui Lin; Lei Zhao; Zhiliang Li; Zhe Wang; Shaun Peggrem; Zhidao Xia; Zengwu Shao
Journal:  Stem Cells Int       Date:  2018-01-30       Impact factor: 5.443

5.  LCRF-0006, a small molecule mimetic of the N-cadherin antagonist peptide ADH-1, synergistically increases multiple myeloma response to bortezomib.

Authors:  Krzysztof M Mrozik; Chee M Cheong; Duncan R Hewett; Jacqueline E Noll; Khatora S Opperman; Alaknanda Adwal; Darryl L Russell; Orest W Blaschuk; Kate Vandyke; Andrew C W Zannettino
Journal:  FASEB Bioadv       Date:  2020-06-15

6.  Cell Type Influences Local Delivery of Biomolecules from a Bioinspired Apatite Drug Delivery System.

Authors:  Jumana Alhamdi; Emily Jacobs; Gloria Gronowicz; Nadia Benkirane-Jessel; Marja Hurley; Liisa Kuhn
Journal:  Materials (Basel)       Date:  2018-09-13       Impact factor: 3.623

Review 7.  Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.

Authors:  Nádia de Cássia Noronha; Amanda Mizukami; Carolina Caliári-Oliveira; Juçara Gastaldi Cominal; José Lucas M Rocha; Dimas Tadeu Covas; Kamilla Swiech; Kelen C R Malmegrim
Journal:  Stem Cell Res Ther       Date:  2019-05-02       Impact factor: 6.832

Review 8.  Preconditioning influences mesenchymal stem cell properties in vitro and in vivo.

Authors:  Chenxia Hu; Lanjuan Li
Journal:  J Cell Mol Med       Date:  2018-02-01       Impact factor: 5.310

9.  TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.

Authors:  Kevin Lynch; Oliver Treacy; Xizhe Chen; Nick Murphy; Paul Lohan; Md Nahidul Islam; Ellen Donohoe; Matthew D Griffin; Luke Watson; Steven McLoughlin; Grace O'Malley; Aideen E Ryan; Thomas Ritter
Journal:  Mol Ther       Date:  2020-05-30       Impact factor: 11.454

Review 10.  Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.

Authors:  Zeli Yin; Keqiu Jiang; Rui Li; Chengyong Dong; Liming Wang
Journal:  Mol Cancer       Date:  2018-12-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.